Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-BREAK: Abatacept SC to IV Switch in RA
NCT01846975Phase 4Completed
- Sponsor
- RBM-Consulting
- Start
- May 2013
- Primary completion
- Dec 2014
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of abatacept in rheumatoid arthritis (RA), sponsored by RBM-Consulting. Started May 2013; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01846975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01846975.